Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cinzia Baldessari
Observed names:
Baldessari, Cinzia,
C. Baldessari,
Cinza Baldessari
Institution:
Azienda Ospedaliero-Universitaria di Modena
Observed institutions:
University of Modena and Reggio Emilia,
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,
Azienda Ospedaliero-Universitaria di Modena
ORCID:
0000-0003-3051-8057
Observed ORCID:
0000-0003-3051-8057
OpenAlex ID:
A5041434581
First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status
2020
·
Francesco Facchinetti
, Giulia Mazzaschi
, et al.
·
European Journal of Cancer
·
153
PDF
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study)
2021
·
Sara Elena Rebuzzi
, Alessio Signori
, et al.
·
Therapeutic Advances in Medical Oncology
·
113
PDF
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%
2020
·
Alessio Cortellini
, Marcello Tiseo
, et al.
·
Cancer Immunology Immunotherapy
·
104
PDF
Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes
2020
·
Alessio Cortellini
, Alex Friedlaender
, et al.
·
Clinical Lung Cancer
·
93
PDF
Bone Metastases and Health in Prostate Cancer: From Pathophysiology to Clinical Implications
2023
·
Cinzia Baldessari
, Stefania Pipitone
, et al.
·
Cancers
·
74
PDF
Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives
2018
·
Chiara Tomasello
, Cinzia Baldessari
, et al.
·
Critical Reviews in Oncology/Hematology
·
69
Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort
2021
·
G. Fornarini
, S.E. Rebuzzi
, et al.
·
ESMO Open
·
65
PDF
A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03)
2022
·
Giuseppe Procopio
, Mélanie Claps
, et al.
·
Tumori Journal
·
58
Stevens–Johnson syndrome during nivolumab treatment of NSCLC
2017
·
M. Salati
, M. Pifferi
, et al.
·
Annals of Oncology
·
54
Smoking status during first‐line immunotherapy and chemotherapy in NSCLC patients: A case–control matched analysis from a large multicenter study
2021
·
Alessio Cortellini
, Andrea De Giglio
, et al.
·
Thoracic Cancer
·
52
PDF
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program
2022
·
S.E. Rebuzzi
, A. Signori
, et al.
·
ESMO Open
·
47
PDF
Impact of body composition, nutritional and inflammatory status on outcome of non-small cell lung cancer patients treated with immunotherapy
2021
·
Cinzia Baldessari
, Giorgia Guaitoli
, et al.
·
Clinical Nutrition ESPEN
·
46
IDH Signalling Pathway in Cholangiocarcinoma: From Biological Rationale to Therapeutic Targeting
2020
·
Massimiliano Salati
, Francesco Caputo
, et al.
·
Cancers
·
45
PDF
NUT midline carcinoma: Current concepts and future perspectives of a novel tumour entity
2019
·
Massimiliano Salati
, Cinzia Baldessari
, et al.
·
Critical Reviews in Oncology/Hematology
·
36
Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study
2021
·
Alessio Cortellini
, Katia Cannita
, et al.
·
European Journal of Cancer
·
35
PDF
On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2
2020
·
O. Caffo
, V. Zagonel
, et al.
·
Annals of Oncology
·
35
PDF
Nivolumab (NIVO) in combination with stereotactic body radiotherapy (SBRT) in pretreated patients (pts) with metastatic renal cell carcinoma (mRCC): First results of phase II NIVES study.
2020
·
Cristina Masini
, Cinzia Iotti
, et al.
·
Journal of Clinical Oncology
·
35
Immunotherapy in Dialysis-Dependent Cancer Patients: Our Experience in Patients With Metastatic Renal Cell Carcinoma and a Review of the Literature
2019
·
Maria Giuseppa Vitale
, Cinzia Baldessari
, et al.
·
Clinical Genitourinary Cancer
·
35
Nivolumab-Induced Impressive Response of Refractory Pulmonary Sarcomatoid Carcinoma with Brain Metastasis
2018
·
Massimiliano Salati
, Cinzia Baldessari
, et al.
·
Case Reports in Oncology
·
33
De Novo Metastatic Prostate Cancer: Are We Moving toward a Personalized Treatment?
2023
·
Claudia Piombino
, Marco Oltrecolli
, et al.
·
Cancers
·
29
PDF
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG
2020
·
Melissa Bersanelli
, Diana Giannarelli
, et al.
·
Therapeutic Advances in Medical Oncology
·
26
Correlation Between Immune-related Adverse Event (IRAE) Occurrence and Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Nivolumab: IRAENE Trial, an Italian Multi-institutional Retrospective Study
2020
·
Maria Giuseppa Vitale
, Stefania Pipitone
, et al.
·
Clinical Genitourinary Cancer
·
25
Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting
2019
·
Roberta Depenni
, Maria Cossu Rocca
, et al.
·
European Journal of Cancer
·
25
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2)
2021
·
Melissa Bersanelli
, Diana Giannarelli
, et al.
·
Journal for ImmunoTherapy of Cancer
·
24
PDF
Role of evaluating tumor‑infiltrating lymphocytes, programmed death‑1 ligand 1 and mismatch repair proteins expression in malignant mesothelioma
2019
·
Lorena Losi
, Federica Bertolini
, et al.
·
International Journal of Oncology
·
22
PDF
Show more works
View as search
Works count:
80
Citation count:
1,622
H-index:
24
I10-index:
38
Year
Topic
Type